Evidence map›Paper›PMID 41997962›Full record

ArticleScientific reports2026

Headspace GC-MS volatiles profiling in leaves of 4 Cymbopogon species and their vapor-phase antibacterial effects.

Mariam O Wahdan, Fatema R Saber, Mariam Hassan, Marwa E Hassan, Mohamed A Farag

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariam O WahdanPostgraduate Program in Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt.
Fatema R SaberPharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt. Fatema.saber@pharma.cu.edu.eg.
Mariam HassanDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt.
Marwa E HassanEgyptian Drug Authority, Giza, 12553, Egypt.
Mohamed A FaragPharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt. mohamed.farag@pharma.cu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aromatic Cymbopogon grasses are valued for their culinary and medicinal applications, yet most species remain underexplored compared to C. citratus. In this study, the aroma profile of leaves from 4 Cymbopogon species (C. citratus, C. nardus, C. martini and C. procerus) was characterized using headspace-SPME-GC-MS-based analysis alongside lemongrass essential oil identifying 44 volatiles. C. citratus, C. nardus, C. procerus, and lemongrass oil were rich in aldehydes, predominantly citral isomers, neral (24.6–33.9%) and geranial (38.5–57.1%), while geraniol alcohol (86.6%) characterized C. martini. Multivariate data analyses were utilized for species classification but failed to reveal geographical origin. The vapor-phase antibacterial activity of Cymbopogon leaves, lemongrass oil, and citral was evaluated against multidrug-resistant ESKAPE pathogens (Enterococcus faecalis, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae). Each specimen revealed inhibition of all Gram-positive and Gram-negative bacteria except E. faecalis, for which only one C. citratus (ctr3) and lemongrass oil were effective at vapor-phase minimum inhibitory concentration (VP-MIC) 1.57 mg/mL and 0.1 µg/mL, respectively. Lemongrass oil showed higher activity than citral against K. pneumoniae (0.05 vs. 0.1 µg/mL) and A. baumannii (0.08 vs. 0.12 µg/mL). The composition of C. procerus aroma is revealed for the first time along its antibacterial effects.

Indexed as

Anti-Bacterial AgentsCymbopogonGas Chromatography-Mass SpectrometryPlant LeavesVolatile Organic CompoundsMicrobial Sensitivity TestsOils, VolatilePlant OilsAnti-Bacterial AgentsOils, VolatilePlant OilsVolatile Organic CompoundsAntibacterialCymbopogonHead Space GC-MSLemongrassSPMEVapor phase -MIC

Identifiers

PMID41997962
PMCPMC13090375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.